Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Reexamination Certificate
2007-09-04
2007-09-04
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
C424S009100, C424S009200, C424S130100, C424S164100, C424S168100, C424S185100, C424S192100, C424S199100, C424S234100, C424S246100, C435S004000, C435S029000, C435S018000, C435S032000, C435S253100
Reexamination Certificate
active
11324517
ABSTRACT:
This invention relates to a novel mycobacterial protein named DES, which appears to share significant amino acid sequence homology with soluble stearoyl-ACP desaturases. The results of allelic exchange experiments, indicate that the des gene may be essential to the survival of mycobacteria. These results coupled with the surface localization, the unique structure of DES, and the fact this antigen is expressed in vivo, and DES protein induces a humoral response in human patients, indicate that the DES protein provides a new target for the design of anti-mycobacterial drugs. This invention provides methods of screening molecules that can inhibit the DES enzyme activity of purified DES protein, in order to identify antibiotic molecules that are capable of inhibiting the growth or survival of mycobacteria. These methods may be practiced by using recombinant DES protein obtained from a recombinant mycobacterium host cell that was transformed with a vector containing the des gene, whose expression is controlled by regulatory or promoter sequences that function in mycobacteria. Another aspect of this invention relates to the molecules that have been identified according to the screening methods as having antibiotic activity: against mycobacteria.
REFERENCES:
patent: 3928140 (1975-12-01), Wyatt et al.
patent: 4320200 (1982-03-01), Higashide et al.
patent: 6010855 (2000-01-01), Jackson et al.
NCBI Sequence Accession No. U49839, submitted Feb. 23, 1996, and Nov. 17, 1997.
Lim et al., “Identification ofMycobaterium tuberulosisDNA Sequences Encoding Exported Proteins by UsingphoAGene Fusions”,J. Bacteriology, vol. 177, No. 1, pp. 59-65 (Jan. 1995).
Jackson et al.,Infection and Immunity, vol. 65, pp. 3882-2889 (Jul. 1997).
Philipp et al.,Proc. Nat'l. Acad. Sci. U.S.A., vol. 93, pp. 3132-3137 (Apr. 1996).
Jackson et al., U.S. Appl. No. 09/422,662 (Oct. 22, 1999).
Altschul, S.F., et al. Basic local alignment search tool. Journal of Molecular Biology. 215:403-410 (1990).
Andersen, A.B., and B. Brennan. Proteins and antigens ofMycobacterium tuberculosis, p. 307-332. In B.R. Bloom (ed.), Tuberculosis: Pathogenesis, Protection, and Control. ASM, Washington, DC. (1994).
Andersen, P. Effective vaccination of mice againstMycobacterium tuberculosisinfection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544 (1994).
Berthet, F.X., et al. Characterization of the M.tuberculosis erpgene encoding a potential cell surface protein with repetitive structures, Microbiology. 141:2123-2130 (1995).
de Boer, H.A., et al. The tac promoter: a functional hybrid derived from the trp and lac promoters. Proc. Natl. Acad. Sci. USA 80, 21-25 (1983).
Braibant, M., et al. Structure of theMycobacterium tuberculosisantigen 88, a protein related to theEscherichia coli PstAperiplasmic phosphate permease subunit. Infection and Immunity. 62:849-854 (1994).
Cahoon, E.B., et al. Redesign of soluble fatty acid desaturases from plants for altered substrate specificity and double bond position. Proc. Nat'l. Acad. Sci. USA 94 (10), pp. 4872-4877 (1997).
Crowe, J. et al., K. 6xHIS-Ni-NTA chromatography as a superior technique in recombinant protein expression/purification. Methods Mol. Biol. 31, 371-387 (1994).
Fox, B.G. et al., Resonance Raman evidence for an Fe-O-Fe center in stearoyl-ACP desaturase. Primary sequence identity with other diiron-oxo proteins. Biochemistry. 33: 12776-12786 (1994).
Fulco, A.J. and K. Bloch. Cofactor requirements for fatty acid desaturation inMycobacterium phlei. Biochim. Biophys. Acta 63:545-546 (1962).
Fulco, A.J., and K. Bloch. Cofactor requirements for the formation of Δ9unsaturated fatty acids inMycobacterium phlei. The Journal of Biological Chemistry. 239:993-997 (1964).
Garbe, T., et al. Expression of theMycobacterium tuberculosis19-kilodalton antigen inMycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect. Immun. 61, 260-267 (1993).
Gordon, S., et al., The application of luciferase as a reporter of environmental regulation of gene expression in mycobacteria. Lett. Appl. Microbiol. 19, 336-340 (1994).
Hasløv, K., et al., Guinea pig cellular immune responses to proteins secreted byMycobacterium tuberculosis. Infection and Immunity. 63:804-810 (1995).
Hatfull, G.F, Genetic transformation of mycobacteria. Trends in microbiology. 1:310-314 (1993).
Hermans, P.W.M., et al. Molecular and immunological characterization of the highly conserved antigen 84 fromMycobacterium tuberculosisandMycobacterium leprae. Infection and Immunity. 63:954-960 (1995).
Horsburgh, C.R. Mycobacterium avium complex infections in the acquired immunodeficiency syndrome. New England, Journal of Medicine, vol. 34, pp. 1332-1338 (1991).
Izard, J.W., and D.A. Kendall. Signal peptides: exquisitely designed transport promoters. Molecular Microbiology. 13:765-773 (1994).
Jacobs, W.R., et al., Genetic systems for mycobacteria. Methods Enzymol. 204:537-555 (1991).
Kashiwabara, Y., and R. Sato. Electron transfer mechanism involved in stearoyl-coenzyme A desaturation by particulate fraction ofMycobacterium phlei. J. Biochem. 74:405-413 (1973).
Keegstra, K., and L.J. Olsen. Chloroplastic precursors and their transport across the envelope membranes. Ann. Rev. Plant Physiol. Plant Mol. Biol. 40:471-501 (1989).
Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:680-685 (1970).
Lee, B.Y., et al., Characterization of the major membrane protein of virulentMycobacterium tuberculosis. Infection and Immunity. 60:2066-2074 (1992).
Legrand, P., and A. Bensadoun. Stearoyl-CoA desaturase activity in cultured rat hepatocytes. Biochimica et Biophysica Acta. 1086:89-94 (1991).
Lindqvist, Y., et al., Crystal structure of Δ9stearoyl-acyl carrier protein desaturase from castor seed and its relationship to other di-iron proteins. EMBO J. 15(16):4081-92 (1996).
Mahenthiralingam, E., et al., Cloning and sequencing of the gene which encodes the highly inducible acetamidase ofMycobacterium smegmatis. J. Gen. Microbiol. 139, 575-583 (1993).
Pal, P.G., and M.A. Horwitz: Immunization with extracellular proteins ofMycobacterium tuberculosisinduces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infection and Immunity. 60:4781-4792 (1992).
Parish, T., et al., Regulation of inducible acetamidase gene ofMycobacterium smegmatis. Microbiology 143, 2267-2276 (1997).
Parish, T. and Stocker, N.G. Development and use of a conditional antisense mutagenesis system in mycobacteria. FEMS Microbiol. Lett. 154, 151-157 (1997).
Pelicic et al.: Efficient allelic exchange and transposon mutagenesis inMycobacterium tuberculosis. Proc. Natl. Sci. USA, 94:10955-10960 (1997).
Pelicic et al.: Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors. Mol. Microbiol., 20:919-925 (1996).
M. Picardeau and V. Vincent: Development of a species-specific probe forMycobacterium xenopiRes. Microbiol., 46:237-263 (1995).
Roche, P.W., et al., Expression ofMycobacterium tuberculosisMPT64 in recombinantM. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin. Exp. Immunol. 103, 226-232 (1996).
Romain, F., et al., Identification of aMycobacterium bovisBCG 45/47—kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infection and immunity. 61:742-750 (1993).
Sakamoto, T., et al. Δ9 acyl lipid desaturases of cyanobacteria. J. Biol. Chem. 269:25576-25580 (1994).
Sanger, F. et al., DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467 (1977).
Shanklin, J., and C. Somerville. Stearoyl-acyl-carrier-protein desaturase from higher plants is structurally unrelated to the animal and fungal homologs. Proceeding of the National Academy of Science of the United States of America. 88:2510-2514 (1991).
Shanklin, J., et al. Eight histidine residues are catalytically essential in a membrane-as
Gicquel Brigitte
Jackson Mary
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Institut Pasteur
Swartz Rodney P
LandOfFree
Process for producing a recombinant protein in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing a recombinant protein in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing a recombinant protein in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3801668